463 related articles for article (PubMed ID: 34003734)
1. TLR7 Agonist Suppresses Group 2 Innate Lymphoid Cell-mediated Inflammation via IL-27-Producing Interstitial Macrophages.
Okuzumi S; Miyata J; Kabata H; Mochimaru T; Kagawa S; Masaki K; Irie M; Morita H; Fukunaga K
Am J Respir Cell Mol Biol; 2021 Sep; 65(3):309-318. PubMed ID: 34003734
[TBL] [Abstract][Full Text] [Related]
2. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation.
Kurowska-Stolarska M; Stolarski B; Kewin P; Murphy G; Corrigan CJ; Ying S; Pitman N; Mirchandani A; Rana B; van Rooijen N; Shepherd M; McSharry C; McInnes IB; Xu D; Liew FY
J Immunol; 2009 Nov; 183(10):6469-77. PubMed ID: 19841166
[TBL] [Abstract][Full Text] [Related]
3. IL-27 Is Essential for Suppression of Experimental Allergic Asthma by the TLR7/8 Agonist R848 (Resiquimod).
Jirmo AC; Daluege K; Happle C; Albrecht M; Dittrich AM; Busse M; Habener A; Skuljec J; Hansen G
J Immunol; 2016 Dec; 197(11):4219-4227. PubMed ID: 27799314
[TBL] [Abstract][Full Text] [Related]
4. Activation through toll-like receptor 2 on group 2 innate lymphoid cells can induce asthmatic characteristics.
Ishii T; Muroi M; Horiguchi K; Tanamoto KI; Nagase T; Yamashita N
Clin Exp Allergy; 2019 Dec; 49(12):1624-1632. PubMed ID: 31494992
[TBL] [Abstract][Full Text] [Related]
5. Persistent Toll-like receptor 7 stimulation induces behavioral and molecular innate immune tolerance.
Michaelis KA; Norgard MA; Levasseur PR; Olson B; Burfeind KG; Buenafe AC; Zhu X; Jeng S; McWeeney SK; Marks DL
Brain Behav Immun; 2019 Nov; 82():338-353. PubMed ID: 31499172
[TBL] [Abstract][Full Text] [Related]
6. IL-33 exacerbates eosinophil-mediated airway inflammation.
Stolarski B; Kurowska-Stolarska M; Kewin P; Xu D; Liew FY
J Immunol; 2010 Sep; 185(6):3472-80. PubMed ID: 20693421
[TBL] [Abstract][Full Text] [Related]
7. IL-17-producing ST2
Cai T; Qiu J; Ji Y; Li W; Ding Z; Suo C; Chang J; Wang J; He R; Qian Y; Guo X; Zhou L; Sheng H; Shen L; Qiu J
J Allergy Clin Immunol; 2019 Jan; 143(1):229-244.e9. PubMed ID: 29625134
[TBL] [Abstract][Full Text] [Related]
8. Role of interleukin-23 in the development of nonallergic eosinophilic inflammation in a murine model of asthma.
Lee HS; Park DE; Lee JW; Sohn KH; Cho SH; Park HW
Exp Mol Med; 2020 Jan; 52(1):92-104. PubMed ID: 31956268
[TBL] [Abstract][Full Text] [Related]
9. Sustained IL-4 priming of macrophages enhances the inflammatory response to TLR7/8 ligand R848.
Banete A; Gee K; Basta S
J Leukoc Biol; 2022 Feb; 111(2):401-413. PubMed ID: 34013552
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.
Johansson K; Malmhäll C; Ramos-Ramírez P; Rådinger M
J Allergy Clin Immunol; 2017 Mar; 139(3):1007-1016.e9. PubMed ID: 27492144
[TBL] [Abstract][Full Text] [Related]
11. Blocking group 2 innate lymphoid cell activation and macrophage M2 polarization: potential therapeutic mechanisms in ovalbumin-induced allergic asthma by calycosin.
Tian C; Liu Q; Zhang X; Li Z
BMC Pharmacol Toxicol; 2024 Apr; 25(1):30. PubMed ID: 38650035
[TBL] [Abstract][Full Text] [Related]
12. Treatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammation.
Nencini F; Pratesi S; Petroni G; Filì L; Cardilicchia E; Casini A; Occhiato EG; Calosi L; Bani D; Romagnani S; Maggi E; Parronchi P; Vultaggio A
Immunology; 2015 Aug; 145(4):570-82. PubMed ID: 25930741
[TBL] [Abstract][Full Text] [Related]
13. The histone deacetylase inhibitor trichostatin A suppresses murine innate allergic inflammation by blocking group 2 innate lymphoid cell (ILC2) activation.
Toki S; Goleniewska K; Reiss S; Zhou W; Newcomb DC; Bloodworth MH; Stier MT; Boyd KL; Polosukhin VV; Subramaniam S; Peebles RS
Thorax; 2016 Jul; 71(7):633-45. PubMed ID: 27071418
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in vivo.
Toki S; Goleniewska K; Reiss S; Zhang J; Bloodworth MH; Stier MT; Zhou W; Newcomb DC; Ware LB; Stanwood GD; Galli A; Boyd KL; Niswender KD; Peebles RS
J Allergy Clin Immunol; 2018 Nov; 142(5):1515-1528.e8. PubMed ID: 29331643
[TBL] [Abstract][Full Text] [Related]
15. Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology.
Baenziger S; Heikenwalder M; Johansen P; Schlaepfer E; Hofer U; Miller RC; Diemand S; Honda K; Kundig TM; Aguzzi A; Speck RF
Blood; 2009 Jan; 113(2):377-88. PubMed ID: 18824599
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells.
Oczypok EA; Milutinovic PS; Alcorn JF; Khare A; Crum LT; Manni ML; Epperly MW; Pawluk AM; Ray A; Oury TD
J Allergy Clin Immunol; 2015 Sep; 136(3):747-756.e4. PubMed ID: 25930197
[TBL] [Abstract][Full Text] [Related]
17. Antitumor Activity of TLR7 Is Potentiated by CD200R Antibody Leading to Changes in the Tumor Microenvironment.
Pilch Z; Tonecka K; Braniewska A; Sas Z; Skorzynski M; Boon L; Golab J; Meyaard L; Rygiel TP
Cancer Immunol Res; 2018 Aug; 6(8):930-940. PubMed ID: 30021725
[TBL] [Abstract][Full Text] [Related]
18. Distinct Roles of LFA-1 and ICAM-1 on ILC2s Control Lung Infiltration, Effector Functions, and Development of Airway Hyperreactivity.
Hurrell BP; Howard E; Galle-Treger L; Helou DG; Shafiei-Jahani P; Painter JD; Akbari O
Front Immunol; 2020; 11():542818. PubMed ID: 33193309
[TBL] [Abstract][Full Text] [Related]
19. Acupuncture inhibited airway inflammation and group 2 innate lymphoid cells in the lung in an ovalbumin-induced murine asthma model.
Cui J; Dong M; Yi L; Wei Y; Tang W; Zhu X; Dong J; Wang W
Acupunct Med; 2021 Jun; 39(3):217-225. PubMed ID: 32539427
[TBL] [Abstract][Full Text] [Related]
20. Blocking IL-19 Signaling Ameliorates Allergen-Induced Airway Inflammation.
Weng YH; Chen WY; Lin YL; Wang JY; Chang MS
Front Immunol; 2019; 10():968. PubMed ID: 31114590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
